Michael Daly1. 1. Stirling Management School, University of Stirling, Stirling, FK9 4LA, United Kingdom. m.daly@abdn.ac.uk
Abstract
OBJECTIVE: Obesity has been shown to produce a state of systematic low-grade inflammation that may have detrimental neuropsychiatric effects. DESIGN AND METHODS: Longitudinal associations between obesity, inflammation, and depressive symptoms amongst a cohort of older English adults over 4 years of follow-up were examined. Participants were 3,891 obese and nonobese people drawn from the English longitudinal study of ageing (ELSA) [aged 64.9 (SD = 8.8) years, 44.6% men]. Depressive symptoms were assessed at baseline and after 4 years of follow-up using the eight-item center for epidemiological studies-depression scale (CES-D). RESULTS: Approximately 26.3% (N = 1,025) of the sample were categorized as obese at baseline. Obesity at baseline was associated with elevated levels of depressive symptoms at follow-up (P < 0.001), in analyses that adjusted for depression levels at baseline and sociodemographic and background variables including the prevalence of permanent illness/disability, alcohol consumption, sedentary behavior, and smoking. In addition, C-reactive protein (CRP) concentrations at baseline were independently associated with CES-D depression scores at follow-up (P = 0.008) in fully adjusted analyses. Subsequent mediation analyses revealed that CRP levels explained ∼20% of the obesity-related longitudinal change in depression scores. CONCLUSION: These data suggest that chronic inflammation may be a key determinant of depressive symptoms in obesity.
OBJECTIVE:Obesity has been shown to produce a state of systematic low-grade inflammation that may have detrimental neuropsychiatric effects. DESIGN AND METHODS: Longitudinal associations between obesity, inflammation, and depressive symptoms amongst a cohort of older English adults over 4 years of follow-up were examined. Participants were 3,891 obese and nonobese people drawn from the English longitudinal study of ageing (ELSA) [aged 64.9 (SD = 8.8) years, 44.6% men]. Depressive symptoms were assessed at baseline and after 4 years of follow-up using the eight-item center for epidemiological studies-depression scale (CES-D). RESULTS: Approximately 26.3% (N = 1,025) of the sample were categorized as obese at baseline. Obesity at baseline was associated with elevated levels of depressive symptoms at follow-up (P < 0.001), in analyses that adjusted for depression levels at baseline and sociodemographic and background variables including the prevalence of permanent illness/disability, alcohol consumption, sedentary behavior, and smoking. In addition, C-reactive protein (CRP) concentrations at baseline were independently associated with CES-D depression scores at follow-up (P = 0.008) in fully adjusted analyses. Subsequent mediation analyses revealed that CRP levels explained ∼20% of the obesity-related longitudinal change in depression scores. CONCLUSION: These data suggest that chronic inflammation may be a key determinant of depressive symptoms in obesity.
Authors: Jinkook Lee; Mark E McGovern; David E Bloom; P Arokiasamy; Arun Risbud; Jennifer O'Brien; Varsha Kale; Peifeng Hu Journal: Econ Hum Biol Date: 2015-09-11 Impact factor: 2.184
Authors: Rita S Strakovsky; Stéphane Lezmi; Jodi A Flaws; Susan L Schantz; Yuan-Xiang Pan; William G Helferich Journal: Toxicol Sci Date: 2013-12-21 Impact factor: 4.849
Authors: Claudia A Grillo; Petra Mulder; Victoria A Macht; Kris F Kaigler; Steven P Wilson; Marlene A Wilson; Lawrence P Reagan Journal: Physiol Behav Date: 2014-02-08
Authors: Aurora Perez-Cornago; Rocio de la Iglesia; Patricia Lopez-Legarrea; Itziar Abete; Santiago Navas-Carretero; Clara I Lacunza; Francisca Lahortiga; Miguel A Martinez-Gonzalez; J Alfredo Martinez; M Angeles Zulet Journal: Nutr J Date: 2014-04-24 Impact factor: 3.271